| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | 0.036 | 0.5 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.5 |